Home RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials
 

Keywords :   


RetroSense Therapeutics' Lead Gene Therapy Candidate Gets FDA Clearance To Proceed To First-In-Human Clinical Trials

2015-09-02 07:40:59| drugdiscoveryonline News Articles

RetroSense Therapeutics LLC, a privately-held biopharmaceutical company, recently announced the Company’s Investigational New Drug (IND) application for RST-001 received clearance from the United States Food and Drug Administration (FDA)

Tags: lead clinical therapy candidate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.03Philip Pelusi Expands Talent Gallery
28.03Apothékary Expands Wellness Offerings With Skincare Supplement
28.03Florida 4-H youth uses 3D printer to save pig
28.03Proposed meat, poultry plant wastewater standards stir up strong opinions
28.03AMPs New Design Scheme Aims to Flex Artificial Intelligence Capabilities in MRFs
28.03'Crypto King' Sam Bankman-Fried faces lengthy jail term
28.03Humans pass more viruses to animals than we catch from them
28.03Humans pass more viruses to animals than we catch from them
More »